Results 151 to 160 of about 2,784 (211)

Long-term outcomes and prognostic factors of major amputation in thromboangiitis obliterans after drug therapy and endovascular procedures: A real-world cohort study. [PDF]

Sci Prog
Xie H, Lu J, Zheng G, Liu X, Chen W.
europepmc   +1 more source

Exploring Causal Relationships between Circulating Inflammatory Proteins and Thromboangiitis Obliterans: A Mendelian Randomization Study. [PDF]

Thromb Haemost
Zhang B, He R, Yao Z, Li P, Niu G, Yan Z, Zou Y, Tong X, Yang M.   +8 more
europepmc   +1 more source

Effect of tobacco on the cardiovascular system [PDF]

, 1948
Scholnick, George L
core   +1 more source

Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells. [PDF]

Biomedicines
Barć P, Lubieniecki P, Antkiewicz M, Kupczyńska D, Barć J, Frączkowska-Sioma K, Dawiskiba T, Dorobisz T, Sekula W, Czuwara B, Małodobra-Mazur M, Baczyńska D, Witkiewicz W, Skóra JP, Janczak D.   +14 more
europepmc   +1 more source

Toll-like receptor signaling pathway involved in pathogenesis of thromboangiitis obliterans through activating of NF-κB. [PDF]

Clinics (Sao Paulo)
Guo F, Bi Y, Yin J, Guo Y.
europepmc   +1 more source

Thromboangiitis obliterans

, 2006
openaire   +2 more sources

Buerger’s disease: providing integrated care [PDF]

core   +2 more sources

[Preliminary application of ulnar cortex transverse transport technique in treatment of upper extremity thromboangiitis obliterans]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Mo X, He C, Zhou J, Chen W, Nie K, Wei Z, Chang S.   +6 more
europepmc   +1 more source